De Backer Marianne
President and CEO
De Backer Marianne has filed 4 SEC Form 4 filings (6 transaction rows) across 1 company, with disclosures dating back to 2026. 4 of those filings fall inside the rolling window. Most recent filing: Apr 30, 2026.
On the most recent filing, De Backer Marianne is listed as President and CEO at Vir Biotechnology, Inc. Inside the rolling window, De Backer Marianne reported no open-market purchases and 3 open-market sales totaling $947K in VIR. The largest disclosed transaction in the window is a sale of 72,559 VIR shares on Apr 6, 2026, worth $664K.
Companies traded
Other insiders at VIR
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$947K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has De Backer Marianne made?
De Backer Marianne has filed 4 SEC Form 4 filings (6 transaction rows) across 1 company since 2026.
Which companies does De Backer Marianne trade?
De Backer Marianne has filed SEC Form 4 disclosures for 1 company, including VIR.
When was De Backer Marianne's most recent SEC Form 4 filing?
De Backer Marianne's most recent SEC Form 4 filing on Tracefour is dated Apr 30, 2026.
What is De Backer Marianne's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, De Backer Marianne is listed as President and CEO.
What is De Backer Marianne's total buy and sell value in the current window?
Inside the rolling retention window, De Backer Marianne bought $0 and sold $947K based on SEC Form 4 filings.
What was De Backer Marianne's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 72,559 VIR shares on 2026-04-06, worth $664K, per SEC Form 4 filings.